Found 285 articles for: "biologics"
Frequency of Thrombocytopenia in Psoriasis Patients Treated With Tumor Necrosis Factor-α Inhibitors
March 2011 | Volume 10 | Issue 3 | Original Article | 280 | Copyright © March 2011
Tumor necrosis factor-α (TNF-α) inhibitors are biologic agents that are currently in wide use for the treatment of psoriasis as well as other inflammatory diseases. Following reports of thro...
Read MoreCancer: This War Is Personal
March 2011 | Volume 10 | Issue 3 | Editorials | 237 | Copyright © March 2011
Disease and Treatment Burden of Psoriasis:Examining the Impact of Biologics
February 2011 | Volume 10 | Issue 2 | Original Article | 189 | Copyright © February 2011
Plaque psoriasis is a chronic, inflammatory skin disease that can be difficult to treat. Traditional systemic agents, topical agents, phototherapy and biologic therapies can be used for patients with...
Read MoreThe Management of Psoriasis in the Age of Biologics: Clinical Update 2009
September 2009 | Volume 8 | Issue 9 | Department | 5 | Copyright © September 2009
This activity is supported by an educational donation provided by Astellas Pharma US Inc. and Amg...
Read MoreFOCUS ON: Biologics that Affect Therapeutic Agents in Dermatology
March 2005 | Volume 4 | Issue 2 | Features | 233 | Copyright © March 2005
Tumor necrosis factor (TNF)-α is one of the oldest known cytokines in human physiology. It is involved in both normal and pathologic states. Virtually every cell and organ in the body are affected b...
Read More